Beyond Avoidance

Dr. Dale T. Umetsu is a physician-scientist who has spent four decades advancing the understanding and treatment of allergic diseases. He served as chief of the division of Allergy and Immunology and a tenured professor at Stanford University before joining Harvard Medical School as the Prince Turki al Saud Professor of Pediatrics. In 2013, Dr. Umetsu joined Genentech as global development lead and played a key role in getting Xolair FDA approved for food allergy. Today, Dr. Umetsu serves as a consultant to biotechnology companies and as a professor at the University of California, San Francisco. His career in medicine and research has been guided by a simple conviction: that patients and families living with food allergy deserve more than avoidance alone.